DE602006012666D1 - Ren eignen und verfahren zu deren herstellung - Google Patents

Ren eignen und verfahren zu deren herstellung

Info

Publication number
DE602006012666D1
DE602006012666D1 DE602006012666T DE602006012666T DE602006012666D1 DE 602006012666 D1 DE602006012666 D1 DE 602006012666D1 DE 602006012666 T DE602006012666 T DE 602006012666T DE 602006012666 T DE602006012666 T DE 602006012666T DE 602006012666 D1 DE602006012666 D1 DE 602006012666D1
Authority
DE
Germany
Prior art keywords
ren
features
production
ren features
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006012666T
Other languages
English (en)
Inventor
Kenneth Alan Simmen
Dominique Louis Nestor Ghislain Surleraux
Tse-I Lin
Oliver Lenz
Pierre Jean-Marie Bernard Raboisson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen R&D Ireland ULC
Original Assignee
Tibotec Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharmaceuticals Ltd filed Critical Tibotec Pharmaceuticals Ltd
Publication of DE602006012666D1 publication Critical patent/DE602006012666D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE602006012666T 2005-05-12 2006-05-12 Ren eignen und verfahren zu deren herstellung Active DE602006012666D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68040505P 2005-05-12 2005-05-12
EP05106214 2005-07-07
EP06075855 2006-04-06
PCT/EP2006/062290 WO2006120252A2 (en) 2005-05-12 2006-05-12 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof

Publications (1)

Publication Number Publication Date
DE602006012666D1 true DE602006012666D1 (de) 2010-04-15

Family

ID=37198763

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006012666T Active DE602006012666D1 (de) 2005-05-12 2006-05-12 Ren eignen und verfahren zu deren herstellung

Country Status (20)

Country Link
US (1) US8022077B2 (de)
EP (1) EP1888580B1 (de)
JP (1) JP5464686B2 (de)
KR (1) KR20080007268A (de)
CN (1) CN101203515B (de)
AR (1) AR054122A1 (de)
AT (1) ATE459623T1 (de)
AU (1) AU2006245676B2 (de)
BR (1) BRPI0609098A2 (de)
CA (1) CA2608301C (de)
DE (1) DE602006012666D1 (de)
DK (1) DK1888580T3 (de)
ES (1) ES2341572T3 (de)
IL (1) IL186881A (de)
MX (1) MX2007014082A (de)
RU (1) RU2444522C2 (de)
SI (1) SI1888580T1 (de)
TW (1) TW200716631A (de)
WO (1) WO2006120252A2 (de)
ZA (1) ZA200709689B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0516751A (pt) * 2004-09-30 2008-09-16 Tibotec Pharm Ltd pirimidinas bicìclicas que inibem hcv
BRPI0609650A2 (pt) * 2005-03-25 2010-04-20 Tibotec Pharm Ltd inibidores heterobicìlicos de hvc
AR056347A1 (es) 2005-05-12 2007-10-03 Tibotec Pharm Ltd Uso de compuestos de pteridina para fabricar medicamentos y composiciones farmaceuticas
ATE541844T1 (de) * 2005-12-21 2012-02-15 Abbott Lab Antivirale verbindungen
US7763731B2 (en) 2005-12-21 2010-07-27 Abbott Laboratories Anti-viral compounds
WO2007081517A2 (en) * 2005-12-21 2007-07-19 Abbott Laboratories Anti-viral compounds
RU2441010C2 (ru) * 2005-12-21 2012-01-27 Эбботт Лэборетриз Противовирусные соединения
WO2008133753A2 (en) 2006-12-20 2008-11-06 Abbott Laboratories Anti-viral compounds
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
EP2376514A2 (de) 2008-12-23 2011-10-19 Pharmasset, Inc. Nukleosidanaloga
NZ593647A (en) 2008-12-23 2013-08-30 Gilead Pharmasset Llc Synthesis of purine nucleosides
MX2011006891A (es) 2008-12-23 2011-10-06 Pharmasset Inc Fosforamidatos de nucleosidos.
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
CA2792601C (en) * 2010-03-10 2015-09-29 Abbott Laboratories Solid compositions of amorphous hcv inhibitors
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
JP5872539B2 (ja) 2010-03-31 2016-03-01 ギリアド ファーマセット エルエルシー プリンヌクレオシドホスホルアミダート
AU2011235112B2 (en) 2010-03-31 2015-07-09 Gilead Pharmasset Llc Nucleoside phosphoramidates
AU2011336632B2 (en) 2010-11-30 2015-09-03 Gilead Pharmasset Llc Compounds
RS60191B1 (sr) 2011-04-08 2020-06-30 Janssen Sciences Ireland Unlimited Co Derivati pirimidina za tretman virusnih infekcija
AU2012334127B2 (en) 2011-11-09 2017-05-18 Janssen Sciences Ireland Uc Purine derivatives for the treatment of viral infections
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
HUE030685T2 (en) 2012-07-13 2017-05-29 Janssen Sciences Ireland Uc Macrocyclic purines for treating viral infections
TR201807076T4 (tr) 2012-10-10 2018-06-21 Janssen Sciences Ireland Uc Viral enfeksiyonların ve diğer hastalıkların tedavisine yönelik pirolo[3,2-d]pirimidin derivatları.
EP2925729B1 (de) 2012-11-16 2017-10-18 Janssen Sciences Ireland UC Heterocyclische substituierte 2-amino-chinazolinderivate zur behandlung von virusinfektionen
KR102300861B1 (ko) 2013-02-21 2021-09-10 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체
DK2978429T3 (en) 2013-03-29 2017-05-15 Janssen Sciences Ireland Uc MACROCYCLIC DEAZA PURINONES FOR TREATING VIRUS INFECTIONS
AU2014270418B2 (en) 2013-05-24 2017-11-30 Janssen Sciences Ireland Uc Pyridone derivatives for the treatment of viral infections and further diseases
ES2645950T3 (es) 2013-06-27 2017-12-11 Janssen Sciences Ireland Uc Derivados de pirrolo[3,2-d]pirimidina para el tratamiento de infecciones víricas y otras enfermedades
CA2913691C (en) 2013-07-30 2022-01-25 Janssen Sciences Ireland Uc Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections
NZ716840A (en) 2013-08-27 2017-06-30 Gilead Pharmasset Llc Combination formulation of two antiviral compounds
ES2813875T3 (es) 2014-01-01 2021-03-25 Medivation Tech Llc Compuestos y procedimientos de uso
EP2905024A1 (de) 2014-02-07 2015-08-12 Institut Quimic De Sarriá Cets, Fundació Privada Pyrido[2,3-d]pyrimidin-7(8H)-on-Derivate zur Behandlung von Flaviviridae Infectionen
WO2018002319A1 (en) 2016-07-01 2018-01-04 Janssen Sciences Ireland Uc Dihydropyranopyrimidines for the treatment of viral infections
ES2912945T3 (es) 2016-09-29 2022-05-30 Janssen Sciences Ireland Unlimited Co Profármacos de pirimidina para el tratamiento de infecciones virales y otras enfermedades
TW201945003A (zh) 2018-03-01 2019-12-01 愛爾蘭商健生科學愛爾蘭無限公司 ２，４－二胺基喹唑啉衍生物及其醫學用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789496A (de) * 1971-10-05 1973-03-29 S M B Anciens Ets J Muelberger
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
RU2340611C2 (ru) * 2000-09-15 2008-12-10 Вертекс Фармасьютикалз Инкорпорейтед Производные пиразола, используемые в качестве ингибиторов протеинкиназы
AU2003202263A1 (en) 2002-01-10 2003-07-30 Bayer Healthcare Ag Roh-kinase inhibitors
JP2003321472A (ja) 2002-02-26 2003-11-11 Takeda Chem Ind Ltd Ｇｒｋ阻害剤
EP1511738A4 (de) * 2002-05-17 2007-05-09 Scios Inc Behandlung von fibroproliferativen erkrankungen unter einsatz von tgf-beta-inhibitoren
WO2004020584A2 (en) 2002-08-27 2004-03-11 Bristol-Myers Squibb Company Antagonists of chemokine receptors
US7148226B2 (en) 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
WO2005032481A2 (en) * 2003-09-30 2005-04-14 Scios Inc. Quinazoline derivatives as medicaments
BRPI0609650A2 (pt) * 2005-03-25 2010-04-20 Tibotec Pharm Ltd inibidores heterobicìlicos de hvc
US20070066632A1 (en) * 2005-03-25 2007-03-22 Scios, Inc. Fused bicyclic inhibitors of TGFbeta

Also Published As

Publication number Publication date
MX2007014082A (es) 2008-04-17
RU2007146173A (ru) 2009-06-20
CN101203515A (zh) 2008-06-18
CN101203515B (zh) 2014-02-26
RU2444522C2 (ru) 2012-03-10
WO2006120252A3 (en) 2007-02-22
IL186881A0 (en) 2008-02-09
TW200716631A (en) 2007-05-01
CA2608301A1 (en) 2006-11-16
DK1888580T3 (da) 2010-06-14
BRPI0609098A2 (pt) 2010-02-17
ES2341572T3 (es) 2010-06-22
KR20080007268A (ko) 2008-01-17
ATE459623T1 (de) 2010-03-15
SI1888580T1 (sl) 2010-06-30
AU2006245676A1 (en) 2006-11-16
AR054122A1 (es) 2007-06-06
CA2608301C (en) 2014-04-22
ZA200709689B (en) 2009-07-29
JP2008540494A (ja) 2008-11-20
WO2006120252A2 (en) 2006-11-16
IL186881A (en) 2015-06-30
EP1888580B1 (de) 2010-03-03
US8022077B2 (en) 2011-09-20
AU2006245676B2 (en) 2012-08-02
JP5464686B2 (ja) 2014-04-09
EP1888580A2 (de) 2008-02-20
US20090131460A1 (en) 2009-05-21

Similar Documents

Publication Publication Date Title
DE602006012666D1 (de) Ren eignen und verfahren zu deren herstellung
ATE556077T1 (de) Tetrahydrochinolinderivate und verfahren zu deren herstellung
DE602006007336D1 (de) Umspritzte behälter und verfahren zu deren herstellung
DE112006000438A5 (de) Verschleissverbesserte Kette sowie Verfahren zu deren Herstellung
DE602006012283D1 (de) Integrierte schaltung und verfahren zu ihrer herstellung
DE602005007419D1 (de) Rohmix-pulverzusammensetzungen und verfahren zu deren herstellung
DE602006020386D1 (de) Duraimplantat und Verfahren zu seiner Herstellung
DE502006003563D1 (de) Polyester-polysiloxan-copolymere und verfahren zu deren herstellung
DE602005020902D1 (de) Kurbel für fahrrad und verfahren zu deren herstellung
DE602006004379D1 (de) Nanodraht-Struktur und Verfahren zu ihrer Herstellung
DE602005015506D1 (de) Filmzubereitung und Verfahren zu deren Herstelllung
DE602005013692D1 (de) Halbleiterbauelement und verfahren zu seiner herstellung
DE602004028462D1 (de) Rfid-etikett und verfahren zu dessen herstellung
DE602005026032D1 (de) Klebende gegenstände mit verbessertem luftaustritt und verfahren zu deren herstellung
DE602006013001D1 (de) Zusammensetzung mit verbesserter stabilität und verfahren zu ihrer herstellung
DE502006009351D1 (de) Feinteiliges azopigment und verfahren zu seiner herstellung
DE602006021029D1 (de) Filtermodul und verfahren zu dessen herstellung
DE602006012326D1 (de) Filtermodul und verfahren zu dessen herstellung
DE602005026176D1 (de) Rollenlose spule und verfahren zu ihrer herstellung
ATE482193T1 (de) Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen
DE602005011751D1 (de) Kameramodul und Verfahren zu dessen Herstellung
DE502005003565D1 (de) Fahrzeug folienbauteil und verfahren zu dessen herstellung
ATE433453T1 (de) Kondensierte pyrrolocarbazole und verfahren zu deren herstellung
DE602006014866D1 (de) Elastisches polyurethangarn und verfahren zu seiner herstellung
ATE496046T1 (de) Arylvinylazacycloalkan-verbindungen und verfahren zu deren herstellung und verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition